You searched for metabolic diseases - Page 43 of 62

More News! 16 Sep 2022

Strategic collaboration for drug to treat NASH, obesity and diabetes announced

…Dong-A will manufacture clinical supplies and initial commercial supplies of the product at its manufacturing facility in Korea. Cardiometabolic assets: a seismic shift for NeuroBo Gil Price, chief executive…

September 16, 2022 - 4 minutesmins - By Liza Laws

In Depth 19 Oct 2023

Biotech’s battle against NASH: The ongoing pursuit of an effective treatment

…deliver novel medicines for people living with rare liver diseases – was a frontrunner in the race to bring the first ever NASH treatment to market. Its lead candidate for…

October 19, 2023 - 8 minutesmins - By Willow Shah-Neville

News and Trends 21 Feb 2023

HKUMed develops nanoparticle-based targeted drug delivery system

…have been published in Nature Communications. Obesity is a major risk factor for a myriad of life-threatening chronic diseases such as diabetes, cardiovascular; and neurodegenerative disorders. TH is an ancient…

February 21, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 24 Feb 2025

Over $3 billion in a month: Why is Eli Lilly starting 2025 on a buying spree?

…as well as in the field of cardiometabolic disorders. Its pact with South Korean biotech OliX Pharmaceuticals was in metabolic dysfunction-associated steatohepatitis (MASH), a chronic liver disease that occurs when…

February 24, 2025 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 26 Oct 2022

Partnership between Paradigm4 and Alnylam accelerates drug target discovery

…obesity and metabolic syndrome – a condition impacting more than 20% of adults worldwide. Cardiometabolic disease These findings support the potential of INHBE as a novel therapeutic target to be…

October 26, 2022 - 3 minutesmins - By Liza Laws

In Depth 13 Nov 2024

Sleep apnea: biotechs snore points in the therapeutic space

…Aging. Untreated forms of the disease can lead to heart, kidney, and metabolic health complications, which is why treating sleep apnea as early as possible is crucial. Table of contents…

November 13, 2024 - 10 minutesmins - By Roohi Mariam Peter

autoimmune disease enzyme hansa medical 1

News and Trends 19 Feb 2018

The FDA Backs a Bacterial Enzyme to Treat a Rare Autoimmune Disease

…Medical, develops enzymes that can help to control the immune system for transplantations and the treatment of autoimmune diseases. The company’s lead candidate, IdeS, has been awarded the FDA’s Orphan…

February 19, 2018 - 2 minutesmins - By Alex Dale

News and Trends 19 Aug 2022

World’s first CAR-T for treatment of inflammatory disorders of the central nervous system approved in China

…officer and chief medical officer of IASO Bio, said: “As one of the first companies to conduct research on CAR-T to treat autoimmune diseases worldwide, our BCMA CAR T-cell therapy…

August 19, 2022 - 2 minutesmins - By Liza Laws

News and Trends 11 Jun 2020

Evox and Lilly Partner to Develop Neuro RNA Drugs in Deal Worth €1.1B

…brain to treat neurological diseases. As part of the deal, Evox will get €17.6M upfront to fund research for the next three years and Lilly will also invest €8.8M into…

June 11, 2020 - 3 minutesmins - By Helen Albert

Interview 18 Nov 2022

How cardioids can usher in the next generation of drug discovery

The California-based Molecular Devices brings automated 3D cell culture and image analysis together with HeartBeat.bio’s cardioid technology to enable unique and scalable drug discovery and cardiac safety testing. Cardiovascular diseases…

November 18, 2022 - 6 minutesmins - By Omnia Ibrahim

News and Trends 24 Oct 2022

Syncona to acquire Applied Genetic Technologies Corporation

…clinical-stage biotechnology company focused on the development and commercialization of adeno-associated virus (AAV)-based gene therapies for the treatment of rare and debilitating diseases with an initial focus on inherited retinal…

October 24, 2022 - 2 minutesmins - By Jim Cornall

gene therapy cardiac rare disease biomarin dinaqor

News and Trends 7 May 2020

BioMarin Partners Swiss Biotech to Develop Cardiac Gene Therapies

US biotech BioMarin has partnered Swiss startup DiNAQOR to develop gene therapies to treat rare, inherited cardiac diseases. DiNAQOR will initially receive an upfront payment from BioMarin, followed by developmental,…

May 7, 2020 - 2 minutesmins - By Helen Albert

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Strategic collaboration for drug to treat NASH, obesity and diabetes announced

Biotech’s battle against NASH: The ongoing pursuit of an effective treatment

HKUMed develops nanoparticle-based targeted drug delivery system

Over $3 billion in a month: Why is Eli Lilly starting 2025 on a buying spree?

Partnership between Paradigm4 and Alnylam accelerates drug target discovery

Sleep apnea: biotechs snore points in the therapeutic space

The FDA Backs a Bacterial Enzyme to Treat a Rare Autoimmune Disease

World’s first CAR-T for treatment of inflammatory disorders of the central nervous system approved in China

Evox and Lilly Partner to Develop Neuro RNA Drugs in Deal Worth €1.1B

How cardioids can usher in the next generation of drug discovery

Syncona to acquire Applied Genetic Technologies Corporation

BioMarin Partners Swiss Biotech to Develop Cardiac Gene Therapies

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!